George E Peoples Selected Research

HER2 peptide (369-377)

1/2021	Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
1/2020	Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.
1/2019	Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
1/2014	The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George E Peoples Research Topics

Disease

60	Neoplasms (Cancer) 10/2021 - 05/2002
54	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2002
8	Melanoma (Melanoma, Malignant) 10/2021 - 07/2005
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2004
6	Hypersensitivity (Allergy) 02/2010 - 12/2007
4	Pain (Aches) 01/2021 - 07/2006
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2010
4	Wounds and Injuries (Trauma) 07/2010 - 06/2005
3	Triple Negative Breast Neoplasms 11/2021 - 01/2020
3	Colonic Neoplasms (Colon Cancer) 05/2014 - 06/2007
3	Neoplasm Metastasis (Metastasis) 01/2009 - 05/2002
2	Adenocarcinoma 09/2022 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 02/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2017 - 05/2002
2	Thyroid Nodule (Nodule, Thyroid) 08/2009 - 05/2008
1	Aggressive Fibromatosis (Desmoid) 01/2021
1	Fatigue 01/2021
1	Disease Progression 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Umbilical Hernia (Omphalocele) 01/2021
1	Colonic Diseases 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2021
1	Gastric Polyposis 01/2021
1	Cardiotoxicity 01/2020
1	Rectal Neoplasms (Rectal Cancer) 03/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2016
1	Residual Neoplasm 01/2016
1	Primary Hyperparathyroidism 01/2012
1	Skin Neoplasms (Skin Cancer) 04/2011
1	Inflammation (Inflammations) 04/2011

Drug/Important Bio-Agent (IBA)

55	VaccinesIBA 10/2021 - 05/2002
33	Peptides (Polypeptides)IBA 06/2020 - 05/2002
17	Protein Subunit VaccinesIBA 11/2021 - 07/2004
16	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 10/2005
16	Proteins (Proteins, Gene)FDA Link 10/2017 - 07/2004
12	AntigensIBA 10/2018 - 04/2005
10	Cancer VaccinesIBA 10/2018 - 02/2009
9	Trastuzumab (Herceptin)FDA Link 11/2021 - 08/2006
6	HLA Antigens (Human Leukocyte Antigens)IBA 08/2017 - 12/2004
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 08/2003
4	HER2 peptide (369-377)IBA 01/2021 - 01/2014
4	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2020 - 07/2004
4	Hormones (Hormone)IBA 01/2020 - 12/2008
4	CytokinesIBA 07/2010 - 05/2002
3	AE37 vaccineIBA 01/2021 - 07/2008
3	Carrier Proteins (Binding Protein)IBA 01/2019 - 02/2011
3	EpitopesIBA 01/2016 - 03/2006
3	Estrogen ReceptorsIBA 02/2010 - 11/2007
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 02/2017
2	ElementsIBA 01/2014 - 01/2014
2	SulfurIBA 08/2013 - 09/2009
2	SolutionsIBA 08/2013 - 09/2009
2	Radioisotopes (Radionuclides)IBA 08/2013 - 09/2009
2	Colloids (Colloid)IBA 08/2013 - 09/2009
2	Lidocaine (Xylocaine)FDA LinkGeneric 08/2013 - 09/2009
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 08/2013 - 09/2009
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2011 - 10/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2010 - 11/2007
2	Immunoglobulin G (IgG)IBA 04/2009 - 10/2008
2	invariant chain (Ii-Key)IBA 01/2009 - 07/2008
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2009 - 11/2007
2	DNA VaccinesIBA 01/2009 - 10/2007
2	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 06/2007 - 05/2002
2	Coloring Agents (Dyes)IBA 06/2007 - 05/2002
2	ErbB Receptors (EGF Receptor)IBA 03/2006 - 07/2004
1	cyclopropapyrroloindoleIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	inproquone (E39)IBA 01/2019
1	human ERBB2 proteinIBA 08/2017
1	Interleukin-2 (IL2)IBA 04/2016
1	Carcinoembryonic AntigenIBA 05/2014
1	lead sulfide (kohl)IBA 01/2014
1	Technetium Tc 99m Sulfur Colloid FDA Link 08/2013
1	peptide AIBA 04/2012
1	insulin receptor-related receptor (IRR)IBA 11/2011
1	sipuleucel-T (APC8015)FDA Link 06/2011
1	Polysaccharides (Glycans)IBA 04/2011
1	Folate Receptor 1IBA 02/2011

Therapy/Procedure

21	Therapeutics 11/2021 - 01/2009
20	Immunotherapy 10/2021 - 03/2006
5	Aftercare (After-Treatment) 01/2021 - 01/2014
3	Extracorporeal Shockwave Therapy 07/2010 - 11/2007
3	Thyroidectomy 08/2009 - 05/2008
2	Mastectomy (Mammectomy) 01/2021 - 12/2011
2	Parathyroidectomy 01/2012 - 08/2009
2	Lymph Node Excision (Lymph Node Dissection) 09/2009 - 05/2002
2	Drug Therapy (Chemotherapy) 01/2009 - 01/2006
1	Chemoradiotherapy 09/2022
1	Neoadjuvant Therapy 09/2022
1	Laparoscopic Cholecystectomy 01/2021
1	Chemoprevention 01/2021
1	Colectomy 01/2021
1	Radiotherapy 01/2021
1	Appendectomy 01/2021
1	Intradermal Injections 08/2013